Molecular Diagnostics and Biomarkers
Improving clinical management
Modern oncology is exploring a number of new directions, including the molecular classification of cancers based on gene mutational status. In the Department of Pathology, we’re focused on making a significant impact on clinical management of patients by pursuing this new area of investigation.
|Dr. Graham Dellaire||Biomarkers in cancer|
|Dr. Paola Marcato||Gene expression profiling of cancer|
|Dr. Dan Gaston||Gene expression profiling of cancer|
|Dr. Karen Bedard||Gene expression profiling of cancer|
|Dr. Zhaolin Xu||Gene mutations in lung cancer|